logo-loader

4D pharma joins Hollywood legend Michael J Fox's Parkinson's initiative

Published: 09:45 18 Dec 2020 GMT

4D pharma PLC -

4D pharma PLC (LON:DDDD) has joined the initiative to find a cure for Parkinson’s disease being sponsored by Hollywood legend Michael J Fox.

In a statement, 4D pharma said its representatives will join the Parkinson's Progression Markers Initiative (PPMI) Scientific Advisory Board and be closely involved in the design and execution of the study.

“The Michael J Fox Foundation has made considerable contributions to the development of therapeutic solutions for the millions of people with Parkinson's disease," said Alex Stevenson, 4D pharma’s chief scientific officer in a statement.

“Joining the PPMI Scientific Advisory Board will enable 4D pharma to bring its leading expertise in Live Biotherapeutics and the gut-brain axis to the pioneering joint effort that is the PPMI," he added.

PPMI was launched by the Michael J Fox Foundation in 2010 to collect and analyse a suite of clinical, imaging and biological data over time to measure and track disease risk, onset and progression and to establish new biomarkers for use in clinical trials of disease-modifying therapies. 

“4D pharma will play an important role as PPMI considers the microbiome as an area of focus, following a growing body of evidence pointing to the gut microbiome as a new frontier in our understanding and treatment of Parkinson's disease," Stevenson added.

Michael J Fox was diagnosed with Parkinson’s in 1991 at the age of 29.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

1 hour, 30 minutes ago